11 Best Pharma Stocks to Buy According to Hedge Funds
The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
Abbvie Inc. (ABBV)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 1,942,300 | $345,146,710 | -22% | 0.05% | |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 1,729,365 | $307,308,161 | +5% | 0.53% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,576,895 | $280,214,242 | +19% | 0.33% |
| 4. | AQR Capital Management Cliff Asness | 1,448,367 | $256,230,604 | -16% | 0.33% |
| 5. | 1,410,800 | $250,699,160 | -25% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.00 | 1,550 | Officer | 17,644 | 2020-03-20 | Filing | |
| $69.00 | 750 | Officer | 16,844 | 2020-03-20 | Filing | |
| $67.50 | 800 | Officer | 16,094 | 2020-03-20 | Filing | |
| $68.18 | 2,200 | Officer | 15,294 | 2020-03-18 | Filing | |
| $69.00 | 750 | Officer | 16,844 | 2020-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $210.53 | 6,168 | 388,929 | 2025-03-03 | Filing | ||
| $205.11 | 92,460 | 395,097 | 2025-02-28 | Filing | ||
| $210.00 | 18,008 | 4,619 | 2025-03-03 | Filing | ||
| $207.19 | 363 | 4,619 | 2025-02-28 | Filing | ||
| $206.62 | 6,811 | 4,982 | 2025-02-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 173,072,078 | $30,754,908,262 | 0.53% | |
| 2. | 142,035,565 | $25,239,719,882 | 0.51% | |
| 3. | 79,621,487 | $14,148,012,258 | 0.55% | |
| 4. | 51,762,491 | $9,198,195,019 | 0.68% | |
| 5. | 39,689,164 | $7,052,764,853 | 0.49% |
News See All
10 Magnificent Dividend Growth Stocks to Invest In
Dividend stocks remain a popular choice among investors due to their ability to generate steady income.
14 Best Performing Dividend Stocks To Buy Now
Dividend stocks have taken a backseat in the market as technology and AI-driven equities have soared to record highs.
Ariel Global Fund Added AbbVie (ABBV) on Dip
Ariel Investments, an investment management company, released its “Ariel Global Fund” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Most Undervalued Long Term Stocks to Buy Now
The stocks showcased initial enthusiasm post Trump’s election, as the S&P 500 saw an increase of 2.5% on the day after the November vote, says U.S. Bank.
12 Best Psychedelic Stocks to Buy in 2025
In contrast to drugs like cocaine or marijuana, psychedelics are strong and give users access to a kind of "alternate reality." One class of hallucinogenic substances that can produce unusual states of...
15 Best S&P 500 Dividend Stocks to Buy Now
Stock market investors have enjoyed strong annual returns over the past two years, but analysts caution that 2025 may not deliver a repeat performance.
S&P 500 Dividend Aristocrats List: Sorted By Hedge Fund Sentiment
Dividend Aristocrats are companies that have consistently increased their dividend payments for at least 25 consecutive years.
10 Best DRIP Stocks To Own Now
Dividend investing is often regarded as a strategy that rewards patience, as it tends to generate stronger returns over the long term.
10 Best Drug Stocks to Buy Now
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.
Billionaire Hedge Funds
